First Zika-positive donations in the continental United States

Transfusion

Volumn 57, Issue 3, 2017, Pages 762-769

  Galel, Susan A ^a   Williamson, Phillip C ^b   Busch, Michael P ^c   Stanek, Danielle ^d   Bakkour, Sonia ^c   Stone, Mars ^c   Lu, Kai ^c   Jones, Scott ^e   Rossmann, Susan N ^f   Pate, Lisa Lee ^a   Rainer, Robert ^g   Boudreaux, Lucretia ^h   Leparc, German F ⁱ   Reik, Rita A ⁱ   Paranjape, Geeta ^j   Oliva, Arcadio J ^k   Butcher, Ann C ^a   Bagha, Rajan ^a   Huynh, Nancy ^a   Duncan, John R ^a   Chowdagam, Chaitanya ^a   Singh, Mansi ^a   Tai, Julie T ^a   Niemiec, John ^a   Dyer, Nicole H C ^a   more..

^a ROCHE MOLECULAR SYSTEMS   (United States)

^b CREATIVE TESTING SOLUTIONS   (United States)

^c BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^d FLORIDA DEPARTMENT OF HEALTH   (United States)

^e QualTex Laboratory   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g The Blood Connection   (United States)

^h Bloodcenter   (United States)

ⁱ OneBlood Inc   (United States)

^j Suncoast Blood Bank   (United States)

^k United States Blood Bank Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; NUCLEIC ACID; VIRUS RNA; VIRUS ANTIBODY;

ARTICLE; BLOOD DONOR; DILUTION; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; UNITED STATES; ZIKA FEVER; ZIKA VIRUS; BLOOD; DONOR SELECTION; FEMALE; MALE; MIDDLE AGED;

ANTIBODIES, VIRAL; BLOOD DONORS; DONOR SELECTION; FEMALE; HUMANS; MALE; MIDDLE AGED; RNA, VIRAL; UNITED STATES; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85013018569     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14029     Document Type: Article

References (23)

1. Marano G, Pupella S, Vaglio S, et al. Zika virus and the never-ending story of emerging pathogens and transfusion medicine. Blood Transfus 2016;14:95-100.
2. Jimenez A, Shaz BH, Bloch EM. Zika virus and the blood supply: what do we know? Transfus Med Rev 2017;31:1-10.
3. Anderson KB, Thomas SJ, Endy TP. The emergence of Zika virus: a narrative review. Ann Intern Med 2016;165:175-83.
4. Besnard M, Lastere S, Teissier A, et al. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014;19. pii: 20751.
5. Deckard DT, Chung WM, Brooks JT, et al. Male-to-male sexual transmission of Zika virus—Texas, January 2016. MMWR Morb Mortal Wkly Rep 2016;65:372-4.
6. Davidson A, Slavinski S, Komoto K, et al. Suspected female-to-male sexual transmission of Zika virus—New York City, 2016. MMWR Morb Mortal Wkly Rep 2016;65:716-7.
7. Hennessey M, Fischer M, Staples JE. Zika virus spreads to new areas—region of the Americas, May 2015-January 2016. MMWR Morb Mortal Wkly Rep 2016;65:55-8.
8. Barjas-Castro ML, Angerami RN, Cunha MS, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016;56:1684-8.
9. Motta IJ, Spencer BR, Cordeiro da Silva SG, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med 2016;375:1101-3.
10. Martines RB, Bhatnagar J, de Oliveira Ramos AM, et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet 2016;388:898-904.
11. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531-9.
12. Faria NR, Azevedo Rdo S, Kraemer MU, et al. Zika virus in the Americas: early epidemiological and genetic findings. Science 2016;352:345-9.
13. Case counts in the US [Internet]. Atlanta: Centers for Disease Control and Prevention; 2016 Nov 16 [cited 2016 Nov 20]. Available from: http://www.cdc.gov/zika/geo/united-states.html.
14. Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill 2014;19. pii: 20761.
15. U.S. Food and Drug Administration. Guidance for industry: recommendations for donor screening, deferral, and product management to reduce the risk of transfusion-transmission of Zika virus. (February 2016) Silver Spring (MD): CBER Office of Communication, Outreach, and Development; 2016.
16. Kuehnert MJ, Basavaraju SV, Moseley RR, et al. Screening of blood donations for Zika virus infection—Puerto Rico, April 3-June 11, 2016. MMWR Morb Mortal Wkly Rep 2016;65:627-8.
17. Adams L, Bello-Pagan M, Lozier M, et al. Update: ongoing Zika virus transmission—Puerto Rico, November 1, 2015-July 7, 2016. MMWR Morb Mortal Wkly Rep 2016;65:774-9.
18. U.S. Food and Drug Administration. Guidance for industry: revised recommendations for reducing the risk of Zika virus transmission by blood and blood components (August 2016). Silver Spring (MD): CBER Office of Communication, Outreach, and Development; 2016.
19. Zika MAC-ELISA [Internet]. Atlanta: Centers for Disease Control and Prevention; 2016 [cited 2016 Nov 28]. Available from: http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM488044.pdf.
20. Advice for people living in or traveling to South Florida [Internet]. Atlanta: Centers for Disease Control and Prevention; 2016 Oct 19 [cited 2016 Nov 20]. Available from: http://www.cdc.gov/zika/intheus/florida-update.html.
21. Lustig Y, Mendelson E, Paran N, et al. Detection of Zika virus RNA in whole blood of imported Zika virus disease cases up to 2 months after symptom onset, Israel, December 2015 to April 2016. Euro Surveill 2016;21. pii: 30269.
22. Murray KO, Gorchakov R, Carlson AR, et al. Prolonged detection of Zika virus in vaginal secretions and whole blood. Emerg Infect Dis 2017;23:99-101.
23. Lanteri MC, Lee TH, Wen L, et al. West Nile virus nucleic acid persistence in whole blood months after clearance in plasma: implication for transfusion and transplantation safety. Transfusion 2014;54:3232-41.